AtriCure Reports Strong Q4 & Full-Year 2025 Results, Guides for Positive 2026 Net Income
ATRC sits 17% above its 52-week low of $28.29.
Summary
AtriCure, Inc. finalized strong Q4 and full-year 2025 financial results, reporting significant revenue growth and a return to profitability in Q4, while also issuing positive 2026 guidance including projected positive net income.
Key Events · Earnings and Guidance · ATRC
-
Strong Q4 2025 Performance
Reported worldwide revenue of $140.5 million, a 13.1% increase year-over-year, with net income of $1.8 million and adjusted EBITDA of $19.9 million.
-
Solid Full-Year 2025 Results
Achieved worldwide revenue of $534.5 million, up 14.9% year-over-year, significantly reducing net loss to $11.4 million and nearly doubling adjusted EBITDA to $61.8 million.
-
Positive 2026 Financial Guidance
Projected full-year 2026 revenue between $600 million and $610 million (12% to 14% growth), with adjusted EBITDA of $80 million to $82 million, and positive net income.
-
Operational Momentum
Growth was driven by expanding use of new products like cryoSPHERE MAX and AtriClip FLEX-Mini, and continued adoption of the EnCompass clamp.
Analysis · ATRC · Industrial Applications And Services
AtriCure, Inc. reported robust financial results for the fourth quarter and full-year 2025, confirming the strong preliminary figures announced on January 12, 2026. The company achieved significant revenue growth and a notable improvement in profitability, moving from a net loss in 2024 to positive net income in Q4 2025. Furthermore, management provided optimistic guidance for full-year 2026, projecting continued revenue growth and, critically, positive net income, signaling a strong operational turnaround and a clear path to sustained profitability. This performance, driven by expanding product adoption, positions the company favorably for future value creation.
How filings like this one have moved
In the 30 days to Oct 5, 2026, 36.9% of the 964 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.65%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, ATRC was trading at $32.97 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $1.6B. The 52-week trading range was $28.29 to $43.18. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.